Senator Enzi honored as BIO Legislator of the Year.
Share:
Press Release Summary:
As part of BIO Legislative Day Fly-In, Senator Michael Enzi (R-WY) was selected as Legislator of the Year for 2009-2010. According to BIO President Jim Greenwood, during service on Senate Health, Education, Labor and Pensions Committee, Senator Enzi has provided thoughtful and responsive leadership on issues critical to biotechnology community, such as drug safety and importation.
Original Press Release:
Senator Enzi Honored as BIO Legislator of the Year
WASHINGTON, D.C. - The Biotechnology Industry Organization (BIO) announced today its selection of Senator Michael Enzi (R-WY) as Legislator of the Year for 2009-2010. Senator Enzi received the award as part of the BIO Legislative Day Fly-In.
"During Senator Enzi's long-standing service on the Senate Health, Education, Labor and Pensions (HELP) Committee, he has provided thoughtful and responsive leadership on issues critical to the biotechnology community such as drug safety and importation," BIO President Jim Greenwood stated. "He played a key role in the creation of a fair and balanced pathway for the approval of biosimilars which protects patient safety and provides incentives for continued innovation."
More than 200 biotechnology industry representatives from 32 states will participate in hundreds of meetings with Members of the House and Senate during the BIO Legislative Day Fly-In. Participants will discuss issues critical to the biotechnology industry including patent reform, NIH/ FDA funding, drug importation risks, and improved eligibility for Small Business Innovation Research grants.
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
